Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_assertion type Assertion NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_head.
- NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_assertion description "[These studies highlight the risks of targeting PI4KA as an anti-hepatitis C virus strategy and also point to important distinctions between genetic and pharmacological studies when selecting host factors as putative therapeutic targets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_provenance.
- NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_assertion evidence source_evidence_literature NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_provenance.
- NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_assertion SIO_000772 24415756 NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_provenance.
- NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_assertion wasDerivedFrom befree-2016 NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_provenance.
- NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_assertion wasGeneratedBy ECO_0000203 NP1144306.RAtIFNF2RuioF8N_vQ1V8g_d1D0XVAgArw5COQf43IaFQ130_provenance.